Landmark decision by the World Health Organization's Executive Board to approve a WHA resolution on hemophilia and other bleeding disorders

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

WFH-WHO-approve

More Like This

PR Newswire associated0

ISTH Releases Evidence-Based Clinical Practice Guideline for Hemophilia Treatment

PR Newswire associated0

Octapharma to present clinical and scientific data that advances our understanding and treatment of bleeding disorders at the 17th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD), which takes place in Frankfurt, Germany, from February 6 - 9, 2024

Sobi and Sanofi's Foundation S extend partnership with the World Federation of Hemophilia Humanitarian Aid Program

PR Newswire associated0

Octapharma's continuing dedication to improving the lives of people with rare bleeding disorders to be showcased at ISTH 2024

PR Newswire associated0

Octapharma to present new clinical and scientific data at ASH 2023 from ongoing research initiatives aimed at advancing care for people living with bleeding disorders

ACCESSWIRE associated0

World Hepatitis Summit 2024 Convenes in Lisbon

PR Newswire associated0

EHA: Bridging Breakthroughs in Hematology

Sobi presents clinical data at WFH 2025 Comprehensive Care Summit